-
Something wrong with this record ?
Melatonin pretreatment does not modify extrasystolic burden in the rat ischemia-reperfusion model
AV. Durkina, OG. Bernikova, NJ. Mikhaleva, NM. Paderin, KA. Sedova, MA. Gonotkov, VS. Kuzmin, JE. Azarov
Language English Country Poland
Document type Journal Article
- MeSH
- Anti-Arrhythmia Agents administration & dosage pharmacology MeSH
- Electrocardiography MeSH
- Myocardial Ischemia drug therapy physiopathology MeSH
- Tachycardia, Ventricular etiology prevention & control MeSH
- Rats MeSH
- Melatonin administration & dosage pharmacology MeSH
- Disease Models, Animal MeSH
- Rats, Wistar MeSH
- Myocardial Reperfusion Injury drug therapy physiopathology MeSH
- Heart Rate drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The mechanism of reentrant ventricular tachyarrhythmias complicating acute myocardial ischemia is largely based on the interaction between an arrhythmogenic substrate and triggers. Melatonin was proposed as an antiarrhythmic medication and was shown to ameliorate the arrhythmogenic substrate. Also, melatonin provides a sympatholytic effect in different settings and might attenuate ectopic activity, which provides reentry triggers. In the present study, we aimed at evaluating the melatonin effects on cardiac sympathetic activity and the incidence of premature ventricular beats during the episode of ischemia-reperfusion. Experiments were done in a total of 26 control and 28 melatonin-treated (10 mg/kg, daily, for 7 days) male rats. Sympathetic fibers density was assessed by glyoxylic acid-induced fluorescence. Continuous electrocardiograms recording was performed during ischemia-reperfusion episodes (5 min/5 min, respectively) induced by reversible coronary occlusion. Myocardial expression of tyrosine hydroxylase, a rate-limiting enzyme of catecholamine biosynthesis was assessed by Western blotting. No differences in the state of sympathetic innervation were observed in histochemical analysis. However, Western blotting analysis demonstrated that melatonin treatment suppressed tyrosine hydroxylase expression in the non-ischemic (p < 0.05 versus control) but not ischemic regions of myocardium. The melatonin-treated animals had longer RR-intervals in the baseline state than the control animals (264 ± 48 ms versus 237 ± 33 ms, p = 0.044, respectively), but this difference decayed during the period of ischemia due to the increase of heart rate in the treated group. The number of premature ventricular beats did not differ between the control and treated groups during the ischemic and reperfusion periods. One-week melatonin pretreatment caused a slight peripheral sympatholytic effect that attenuated during ischemia and completely disappeared by the onset of reperfusion. The slight expression of sympathetic downregulation was associated with the lack of any effect of melatonin on extrasystolic burden. Collectively, the data suggest that melatonin cannot target the triggers of reentrant arrhythmias.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004653
- 003
- CZ-PrNML
- 005
- 20220127145103.0
- 007
- ta
- 008
- 220113s2021 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.26402/jpp.2021.1.15 $2 doi
- 035 __
- $a (PubMed)34272351
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Durkina, A V $u Department of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Russia. sashadurkina@mail.ru
- 245 10
- $a Melatonin pretreatment does not modify extrasystolic burden in the rat ischemia-reperfusion model / $c AV. Durkina, OG. Bernikova, NJ. Mikhaleva, NM. Paderin, KA. Sedova, MA. Gonotkov, VS. Kuzmin, JE. Azarov
- 520 9_
- $a The mechanism of reentrant ventricular tachyarrhythmias complicating acute myocardial ischemia is largely based on the interaction between an arrhythmogenic substrate and triggers. Melatonin was proposed as an antiarrhythmic medication and was shown to ameliorate the arrhythmogenic substrate. Also, melatonin provides a sympatholytic effect in different settings and might attenuate ectopic activity, which provides reentry triggers. In the present study, we aimed at evaluating the melatonin effects on cardiac sympathetic activity and the incidence of premature ventricular beats during the episode of ischemia-reperfusion. Experiments were done in a total of 26 control and 28 melatonin-treated (10 mg/kg, daily, for 7 days) male rats. Sympathetic fibers density was assessed by glyoxylic acid-induced fluorescence. Continuous electrocardiograms recording was performed during ischemia-reperfusion episodes (5 min/5 min, respectively) induced by reversible coronary occlusion. Myocardial expression of tyrosine hydroxylase, a rate-limiting enzyme of catecholamine biosynthesis was assessed by Western blotting. No differences in the state of sympathetic innervation were observed in histochemical analysis. However, Western blotting analysis demonstrated that melatonin treatment suppressed tyrosine hydroxylase expression in the non-ischemic (p < 0.05 versus control) but not ischemic regions of myocardium. The melatonin-treated animals had longer RR-intervals in the baseline state than the control animals (264 ± 48 ms versus 237 ± 33 ms, p = 0.044, respectively), but this difference decayed during the period of ischemia due to the increase of heart rate in the treated group. The number of premature ventricular beats did not differ between the control and treated groups during the ischemic and reperfusion periods. One-week melatonin pretreatment caused a slight peripheral sympatholytic effect that attenuated during ischemia and completely disappeared by the onset of reperfusion. The slight expression of sympathetic downregulation was associated with the lack of any effect of melatonin on extrasystolic burden. Collectively, the data suggest that melatonin cannot target the triggers of reentrant arrhythmias.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiarytmika $x aplikace a dávkování $x farmakologie $7 D000889
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a elektrokardiografie $7 D004562
- 650 _2
- $a srdeční frekvence $x účinky léků $7 D006339
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a melatonin $x aplikace a dávkování $x farmakologie $7 D008550
- 650 _2
- $a ischemická choroba srdeční $x farmakoterapie $x patofyziologie $7 D017202
- 650 _2
- $a reperfuzní poškození myokardu $x farmakoterapie $x patofyziologie $7 D015428
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a komorová tachykardie $x etiologie $x prevence a kontrola $7 D017180
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bernikova, O G $u Department of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Russia
- 700 1_
- $a Mikhaleva, N J $u Department of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Russia
- 700 1_
- $a Paderin, N M $u Department of Molecular Immunology and Biotechnology, Institute of Physiology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Russia
- 700 1_
- $a Sedova, K A $u Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic
- 700 1_
- $a Gonotkov, M A $u Department of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Russia
- 700 1_
- $a Kuzmin, V S $u Department of Human and Animal Physiology, Biological Faculty, Lomonosov Moscow State University, Moscow, Russia
- 700 1_
- $a Azarov, J E $u Department of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Russia
- 773 0_
- $w MED00002908 $t Journal of physiology and pharmacology : an official journal of the Polish Physiological Society $x 1899-1505 $g Roč. 72, č. 1 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34272351 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145100 $b ABA008
- 999 __
- $a ok $b bmc $g 1751959 $s 1155802
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 72 $c 1 $e 20210713 $i 1899-1505 $m Journal of physiology and pharmacology $n J Physiol Pharmacol $x MED00002908
- LZP __
- $a Pubmed-20220113